T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
OppFi
OPFI
$601M
| $138K | ﹤0.01% |
12,148
| – | – |
|
2852
DiaMedica Therapeutics
DMAC
$370M
| $136K | ﹤0.01% |
19,660
+6,292
| +47% | +$34.1K |
|
2853
El Pollo Loco
LOCO
$464M
| $136K | ﹤0.01% |
14,019
+1,329
| +10% | +$13.9K |
|
2854
Safe Bulkers
SB
$777M
| $136K | ﹤0.01% |
30,629
+2,104
| +7% | +$8.93K |
|
|
BZAI
2855
Blaize Holdings
BZAI
$166M
| $136K | ﹤0.01% |
+39,200
| New | +$139K |
|
2856
LifeVantage
LFVN
$81.1M
| $133K | ﹤0.01% |
13,634
| – | – |
|
2857
Liberty Latin America Class A
LILA
$1.67B
| $132K | ﹤0.01% |
23,328
| – | – |
|
|
WOW
2858
DELISTED
WideOpenWest
WOW
| $132K | ﹤0.01% |
25,576
+2,134
| +9% | +$9.56K |
|
2859
LifeMD
LFMD
$159M
| $131K | ﹤0.01% |
19,282
+1,529
| +9% | +$12.6K |
|
2860
NN Inc
NNBR
$301M
| $131K | ﹤0.01% |
63,163
-39,671
| -39% | -$89.1K |
|
2861
Pixelworks
PXLW
$44.2M
| $130K | ﹤0.01% |
11,857
| – | – |
|
2862
Quantum-Si Incorporated
QSI
$189M
| $130K | ﹤0.01% |
92,034
-28,472
| -24% | -$41.2K |
|
|
TE
2863
T1 Energy
TE
$1.48B
| $128K | ﹤0.01% |
58,638
+1,576
| +3% | +$2.51K |
|
|
HSHP
2864
Himalaya Shipping
HSHP
$739M
| $127K | ﹤0.01% |
15,310
| – | – |
|
2865
loanDepot
LDI
$313M
| $127K | ﹤0.01% |
41,283
| – | – |
|
2866
Nano X Imaging
NNOX
$74.3M
| $127K | ﹤0.01% |
34,110
+1,927
| +6% | +$8.58K |
|
2867
Viemed Healthcare
VMD
$355M
| $127K | ﹤0.01% |
18,564
+1,663
| +10% | +$11.3K |
|
2868
VTEX
VTEX
$630M
| $127K | ﹤0.01% |
28,917
| – | – |
|
2869
Neuropace
NPCE
$504M
| $125K | ﹤0.01% |
12,058
| – | – |
|
2870
TechTarget
TTGT
$275M
| $125K | ﹤0.01% |
21,396
+353
| +2% | +$2.34K |
|
|
ABX
2871
Abacus Global Management
ABX
$836M
| $124K | ﹤0.01% |
+21,605
| New | +$128K |
|
2872
Abeona Therapeutics
ABEO
$354M
| $123K | ﹤0.01% |
23,158
+1,249
| +6% | +$7.92K |
|
2873
Design Therapeutics
DSGN
$916M
| $123K | ﹤0.01% |
16,314
| – | – |
|
2874
Enanta Pharmaceuticals
ENTA
$404M
| $122K | ﹤0.01% |
+10,146
| New | +$81.1K |
|
2875
908 Devices
MASS
$415M
| $122K | ﹤0.01% |
13,827
+1,417
| +11% | +$9.42K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.